Recent News

• 12.11.2025 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 12.11.2025 - 8-K - Current report
• 12.11.2025 - Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
• 11.19.2025 - Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
• 11.13.2025 - 8-K - Current report
• 11.13.2025 - Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
• 11.12.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 10.31.2025 - ARS - Annual Report to Security Holders
• 10.31.2025 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 10.31.2025 - DEF 14A - Definitive proxy statements

Recent Filings

• 11.13.2025 - 8-K Current report
• 11.13.2025 - EX-99.1 EX-99.1
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.31.2025 - ARS Annual Report to Security Holders
• 10.31.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 10.31.2025 - DEF 14A Other definitive proxy statements
• 10.14.2025 - EX-99.1 EX-99.1
• 10.14.2025 - 424B5 Prospectus [Rule 424(b)(5)]